Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × mazdutide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Lymphoma, Follicular 1 Diabetes Mellitus, Type 2 1 Dementia 1 Cognitive Dysfunction 1

Interventions

Metformin 134 Clomiphene 46 Letrozole 37 Inositol 31 Progesterone 16 Folic Acid 16 Exercise 14 Chorionic Gonadotropin 13 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Estradiol 12 Caloric Restriction 12 cetrorelix 11 Contraceptives, Oral 11 Cholecalciferol 10 Triptorelin Pamoate 9 Spironolactone 9 Pioglitazone 9 Tablets 8 Menotropins 8 High-Intensity Interval Training 8 Diet 8 Gonadotropins 7 Acupuncture Therapy 7 follitropin alfa 6 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Flutamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06519656 2024-10-24

Efficacy of Mazdutide for Treating PCOS

Shanghai Zhongshan Hospital

Phase 1/2 Recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡